Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction

← catalyst calendar

NCT06333015

Sponsored by Bausch & Lomb Incorporated (industry) · BLCO — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
304actual
Sites
16
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-08-07actualWhen the study began enrolling
Primary completion2026-06-11actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2026-06-11actualThe whole study's end, after follow-up
First posted2024-03-27actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-07-13actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Cataract

Interventions

  • Device: enVista Beyond EY (EDF) IOL
  • Device: enVista MX60E monofocal IOL

Primary outcomes

what the primary-completion date above is the date OF
Mean Monocular Photopic Distance Corrected Intermediate Visual Acuity (DCIVA) of first implanted eyes at Post-Operative Visit 4.
measured Day 120 to Day 180 after second eye implantation
Median Monocular Photopic Distance Corrected Intermediate Visual Acuity (DCIVA) of first implanted eyes at Post-Operative Visit 4.
measured Day 120 to Day 180 after second eye implantation
Negative lens induced distance-corrected Depth of focus (D) at 0.20 logMAR of first implanted eyes at Post-Operative Visit 4.
measured Day 120 to Day 180 after second eye implantation
Mean monocular best-corrected distance visual acuity (BCDVA) (logMAR) of first implanted eyes at Post-Operative Visit 4.
measured Day 120 to Day 180 after second eye implantation
Rates with postoperative monocular BCDVA of 20/40 (0.30 logMAR) or better of first implanted eyes at Post-Operative Visit 4.
measured Day 120 to Day 180 after second eye implantation

Permalink · BLCO's whole pipeline · Catalyst calendar · Every registered study · What changed